RESUMEN
Gardeniae Fructus has the traditional effects of promoting intelligence and inducing resuscitation, but its mechanism is unclear. In this study, the relationship between Gardeniae Fructus's traditional effect of promoting intelligence and inducing resuscitation and anti-Alzheimer's disease effect was taken as the starting point to investigate the anti-Alzheimer's disease mechanism of the major absorbed components in Gardeniae Fructus by the network pharmacology method. The network pharmacology research model of "absorbed composition-target-pathway-disease" was adopted. In this study, the active components screening and target prediction technology were used to determine the active components and targets of Gardeniae Fructus in treatment of Alzheimer's disease. The enrichment pathway and biological process of Gardeniae Fructus were studied by using the bioinformatics annotation database(DAVID), and the results of molecular docking validation network analysis were used to elaborate the mechanism of Gardeniae Fructus in treatment of Alzheimer's disease. It was found that 35 absorbed components of Gardeniae Fructus not only regulated 48 targets such as cholines-terase(BCHE) and carbonic anhydrase 2(CA2), but also affected 11 biological processes(e.g. transcription factor activity, nuclear receptor activity, steroid hormone receptor activity, amide binding and peptide binding) and 7 metabolic pathways(MAPK signaling pathway, Alzheimer disease and estrogen signaling pathway, etc.). Molecular docking results showed that more than 60% of the active components could be well docked with key targets, and the relevant literature also showed that the active components could inhibit the MAPK1 expression of key targets, indicating a high reliability of results. These results indicated that Gardeniae Fructus may play its anti-Alzheimer's disease action via a "multi-ingredients-multi-targets and multi-pathways" mode, providing a scientific basis for further drug research and development.
Asunto(s)
Humanos , Enfermedad de Alzheimer , Medicamentos Herbarios Chinos , Gardenia , Simulación del Acoplamiento Molecular , Reproducibilidad de los ResultadosRESUMEN
<p><b>AIM</b>To study the role of NO in the midbrain periaqueductal gray (PAG) in the development of stress-induced hypertension (SIH).</p><p><b>METHODS</b>The model of stress-induced hypertension (SIH) rat was established by electric-foot in company with noise, NADPH-d histochemistry technique was used to investigate the change of nitric oxide synthase (NOS) positive neurons. Selecting and using microinjection and radioimmunoassay, we studied the effects of blood pressure and the content of Ach in rostral ventrolateral medulla (RVLM) after microinjection of L-NNA into PAG.</p><p><b>RESULTS</b>(1) The blood pressure increased, the cell number decreased and the grey degree value increased for the NOS positive neurons of PAG dorsolateral subdivision in SIH rats, and the content of Ach increased in RVLM. (2) Following microinjection of 100 mmol/L 0.1 microl L-NNA into PAG, the mean arterial pressure (MAP) and the content of Ach in RVLM increased in control rats, whereas the change of MAP was significantly smaller in SIH rats than control.</p><p><b>CONCLUSION</b>The plastic change of NOS positive neurons of PAG in SIH rats may be involved in the development of SIH, which may be mediated by Ach in RVLM.</p>